| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.51B | 38.05B | 38.74B | 40.42B | 39.19B | 31.78B |
| Gross Profit | 10.11B | 10.98B | 9.96B | 8.29B | 8.90B | 7.00B |
| EBITDA | 5.82B | 6.07B | 5.86B | 1.86B | 3.89B | 3.18B |
| Net Income | 3.17B | 3.28B | 3.16B | -1.85B | 1.56B | 726.00M |
Balance Sheet | ||||||
| Total Assets | 40.24B | 42.87B | 40.41B | 39.96B | 41.61B | 37.41B |
| Cash, Cash Equivalents and Short-Term Investments | 4.79B | 6.49B | 5.12B | 4.08B | 2.86B | 3.05B |
| Total Debt | 6.20B | 5.96B | 7.74B | 9.80B | 10.79B | 8.32B |
| Total Liabilities | 14.63B | 13.24B | 15.04B | 17.69B | 19.36B | 16.84B |
| Stockholders Equity | 20.85B | 24.25B | 20.69B | 18.19B | 19.10B | 18.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.53B | 3.77B | 2.64B | -2.70B | -285.00M |
| Operating Cash Flow | 0.00 | 6.48B | 5.18B | 4.91B | -540.00M | 1.04B |
| Investing Cash Flow | 0.00 | -5.09B | -1.18B | -3.02B | -1.50B | -1.32B |
| Financing Cash Flow | 0.00 | -2.39B | -2.55B | -1.61B | 1.82B | -762.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥105.78B | 17.95 | ― | 1.30% | 26.33% | 11.15% | |
74 Outperform | ¥21.73B | 6.70 | ― | 1.82% | -1.80% | 3.81% | |
74 Outperform | ¥108.88B | 18.70 | 15.07% | 1.74% | 7.82% | 64.90% | |
69 Neutral | ¥54.76B | 13.50 | ― | 2.92% | -5.24% | 17.53% | |
65 Neutral | ¥51.85B | 19.62 | ― | 4.37% | -3.84% | -43.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥894.89B | -17.36 | -2.50% | 3.49% | -4.57% | -190.44% |